Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Auspex Pharmaceuticals Inc patents


Recent patent applications related to Auspex Pharmaceuticals Inc. Auspex Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Auspex Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Auspex Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Auspex Pharmaceuticals Inc-related inventors


Benzoquinolone inhibitors of vmat2

The present invention relates to new benzoquinolone inhibitors of vmat2, pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc

Benzoquinoline inhibitors of vesicular monoamine transporter 2

The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (vmat2), pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc

Tetrahydrocarbazole inhibitors of sirt1 receptors

Described are deuterium-substituted tetrahydrocarbazole compounds of formulae i, ii, or iii which are inhibitors of sirtuin 1 (sirt1). Also described are pharmaceutical compositions comprising the deuterium-substituted tetrahydrocarbazole compounds, and methods of use thereof.. ... Auspex Pharmaceuticals Inc

Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity

Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management of psychotropic disorders, anxiety disorder, generalized anxiety disorder, depression, post-traumatic stress disorder, obsessive-compulsive disorder, panic disorder, hot flashes, senile dementia, migraine, hepatopulmonary syndrome, chronic pain, nociceptive pain, neuropathic pain, painful diabetic retinopathy, bipolar depression, obstructive sleep apnea, psychiatric disorders, premenstrual dysphoric disorder, social phobia, social anxiety disorder, urinary incontinence, anorexia, bulimia nervosa, obesity, ischemia, head injury, calcium overload in brain cells, drug dependence, and/or premature ejaculation are described.. . ... Auspex Pharmaceuticals Inc

Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds

Described are deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds of structural formula (i), which are agonists of 5-hydroxytryptamine receptors. Also described are pharmaceutical compositions comprising the deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compounds, and methods of use thereof.. ... Auspex Pharmaceuticals Inc

Deuterium-substituted oxazepin compounds

Described are deuterium-substituted oxazepin compounds of structural formula i, which are inhibitors/blockers of the late sodium current. Also described are pharmaceutical compositions comprising the deuterium-substituted oxazepin compounds, and methods of use thereof.. ... Auspex Pharmaceuticals Inc

Methods for the treatment of abnormal involuntary movement disorders

Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.. . ... Auspex Pharmaceuticals Inc

Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2

Described are dimethoxyphenyl inhibitors of vmat2, pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc

Deuterium-substituted oxadiazoles

Described are deuterated modulators of s1p1 receptors, pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc

Methods for the treatment of abnormal involuntary movement disorders

Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.. . ... Auspex Pharmaceuticals Inc

Dihydroxyphenyl neurotransmitter compounds, compositions and methods

The present invention relates to new dihydoxyphenyl modulators of neurotransmitter levels, pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc

Benzoquinolone inhibitors of vmat2

The present invention relates to new benzoquinolone inhibitors of vmat2, pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc

Methods of manufacturing benzoquinoline compounds

The present invention relates to new methods of manufacturing benzoquinoline inhibitors of vesicular monoamine transporter 2 (vmat2), and intermediates thereof.. . ... Auspex Pharmaceuticals Inc

Tetrahydrocarbazole inhibitors of sirt1 receptors

Described are deuterium-substituted tetrahydrocarbazole compounds of formulae i, ii, or iii which are inhibitors of sirtuin 1 (sirt1). Also described are pharmaceutical compositions comprising the deuterium-substituted tetrahydrocarbazole compounds, and methods of use thereof.. ... Auspex Pharmaceuticals Inc

07/06/17 / #20170190654

Methods of manufacturing benzoquinoline compounds

The present invention relates to new methods of manufacturing benzoquinoline inhibitors of vesicular monoamine transporter 2 (vmat2), and intermediates thereof.. . ... Auspex Pharmaceuticals Inc

06/15/17 / #20170166562

Benzoquinoline inhibitors of vesicular monoamine transporter 2

The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (vmat2), pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc

06/01/17 / #20170151227

Methods for the treatment of abnormal involuntary movement disorders

Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.. . ... Auspex Pharmaceuticals Inc

03/30/17 / #20170087147

Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2

The present invention relates to new pharmaceutical compositions comprising benzoquinoline compounds, and methods to inhibit vesicular monoamine transporter 2 (vmat2) activity in a subject for the treatment of chronic hyperkinetic movement disorders.. . ... Auspex Pharmaceuticals Inc

01/05/17 / #20170002015

Cyclopropyl modulators of p2y12 receptor

The present invention relates to new cyclopropyl modulators of p2y12 receptor activity, pharmaceutical compositions thereof, and methods of use thereof.. . ... Auspex Pharmaceuticals Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Auspex Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Auspex Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###